Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection

Journal of the American Academy of Dermatology

Volumn 36, Issue 3, 1997, Pages 495-496

  Driscoll, M S ^a   Tyring, S K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; AZITHROMYCIN; CEFMETAZOLE; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; DOXYCYCLINE; ERYTHROMYCIN; ERYTHROMYCIN ETHYLSUCCINATE; IMIPENEM; IMMUNOSUPPRESSIVE AGENT; KANAMYCIN; MINOCYCLINE; OFLOXACIN; PREDNISONE; SULFAFURAZOLE; SULFAMETHOXAZOLE; TOBRAMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; ERYTHEMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM CHELONEI; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; SKIN INFECTION;

EID: 0030896985     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(97)80242-3     Document Type: Article

References (10)

1. Woods G.L. Washington J.A. II. Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects Rev Infect Dis 9 1987 275 294
2. Gremillion D.H. Munsch S.B. Lerner C.J. Injection site abscesses caused by Mycobacterium chelonei Infect Control 4 1983 25 28
3. Borghans J.G.A. Stanford J.L. Mycobacterium chelonei in abscesses after injection of diphtheria-pertussis-tetanuspolio vaccine Am Rev Respir Dis 107 1973 1 8
4. Safranek T.J. Jarvis W.R. Carson L.A. Mycobacterium chelonei wound infections after plastic surgery employing contaminated gentian violet skin-marking solution N Engl J Med 317 1987 197 201
5. Wallace R.J. Brown B.A. Onyi G.O. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin J Infect Dis 166 1992 405 412
6. Cooper J.F. Lichtenstein M.J. Graham B.S. Mycobacterium chelonae: a cause of nodular skin lesions with a proclivity for renal transplant patients Am J Med 86 1989 173 177
7. Wallace R.J. Tanner D. Brennan P.J. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae Ann Intern Med 119 1993 482 486
8. Brown B.A. Wallace R.J. Onyi G.O. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms Antimicrob Agents Chemother 36 1992 180 184
9. Tebas P. Sultan F. Wallace R.J. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient Clin Infect Dis 20 1995 443 444
10. Franck N. Cabié A. Villette B. Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin J Am Acad Dermatol 28 1993 1019 1021